Medicine
Prismasol BK0/0/1.2 5.4 g/2.44 g/3.09 g/6.46 g per L injection
Prismasol BK0/0/1.2 5.4 g/2.44 g/3.09 g/6.46 g per L injection is a prescription medicine containing Lactic acid, Magnesium chloride, Sodium bicarbonate and Sodium chloride for intravenous use, marketed by Vantive US Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze or expose to excessive heat. Store at 20°C to 25°C (68°F to…
Key facts
- Active ingredient (INN)
- Lactic acid, Magnesium chloride, Sodium bicarbonate and Sodium chloride
- Brand
- Prismasol BK0/0/1.2
- Strength
- 5.4 g/2.44 g/3.09 g/6.46 g per L
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 2 bags
- Marketing authorisation holder
- Vantive US Healthcare
- Manufacturer
- Vantive US Healthcare
- Origin register
- US FDA, United States
- Storage
- Do not freeze or expose to excessive heat. Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15ºC to 30ºC (59ºF to 86ºF).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 October 2006
- Identifiers
- DailyMed set ID 7f675fee-8940-4ece-bb0c-75ac79d8708cNDC 24571-113Application NDA021703
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 bag in 1 case / 5 L in 1 bag | 24571-113-06 | Vantive US Healthcare | 10 October 2008 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Lactic acid, Magnesium chloride, Sodium bicarbonate and Sodium chloride is a fixed-dose combination of an osmotic laxative and a calculi dissolution agent. MedsAcross supplies Lactic acid, Magnesium chloride, Sodium bicarbonate and Sodium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Lactic acid, Magnesium chloride, Sodium bicarbonate and Sodium chlorideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- PRISMASOL BGK2/0 prescribing information (Vantive US Healthcare) · U.S. National Library of Medicine, DailyMed
Need Prismasol BK0/0/1.2 5.4 g/2.44 g/3.09 g/6.46 g per L injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.